• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[如何创建用于抗高血压和降血脂治疗的合作患者]

[How to create cooperative patient for antihypertensive and hypolipidemic therapy].

作者信息

Piťha Jan

出版信息

Vnitr Lek. 2017 Spring;63(4):272-276.

PMID:28520451
Abstract

Patient drug adherence is a major problem especially in the prevention of cardiovascular disease of atherosclerotic origin. On one hand, antihypertensive drugs and hypolipidemic drugs/statins are among the most successful, ones the other hand, they are among the drugs which are most frequently skipped by the patients. Improvement could be realized by education of patients, more frequent follow-ups, as well as by the use of new technologies involving specific dispensers and other, even more sophisticated methods. Nevertheless, among the most successful strategies is the simplification of medication, particularly the use of drugs with a longer half-life and the use of combination of several drugs in a single tablet. Therefore, we have quite wide range of options to improve patient compliance. However, some disadvantages should be kept in mind associated with these techniques. The aim of this article is to discuss potential problems and solutions associated with patient adherence/compliance with respect to antihypertensive and hypolipidemic treatment with an emphasis on practical approach.Key words: drug adherence - dyslipidemia - hypertension - pharmacotherapy.

摘要

患者的药物依从性是一个主要问题,尤其是在预防动脉粥样硬化性心血管疾病方面。一方面,抗高血压药物和降血脂药物/他汀类药物是最成功的药物之一,另一方面,它们也是患者最常漏服的药物。可以通过对患者进行教育、更频繁的随访以及使用涉及特定配药器和其他更复杂方法的新技术来实现改善。然而,最成功的策略之一是简化用药,特别是使用半衰期更长的药物以及在单片制剂中使用几种药物的组合。因此,我们有相当广泛的选择来提高患者的依从性。然而,应该记住与这些技术相关的一些缺点。本文的目的是讨论与患者在抗高血压和降血脂治疗方面的依从性相关的潜在问题和解决方案,重点是实用方法。关键词:药物依从性 - 血脂异常 - 高血压 - 药物治疗

相似文献

1
[How to create cooperative patient for antihypertensive and hypolipidemic therapy].[如何创建用于抗高血压和降血脂治疗的合作患者]
Vnitr Lek. 2017 Spring;63(4):272-276.
2
[Achievement of therapeutic objectives].[治疗目标的达成]
Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:20-4. doi: 10.1016/S0214-9168(14)70022-1.
3
[News in the treatment of hypertension and dyslipidemia].[高血压和血脂异常的治疗进展]
Vnitr Lek. 2017 Summer;63(5):333-337.
4
Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.单片复方制剂在高血压和/或血脂异常患者的日常实践中可带来更好的依从性和临床结局:一项荟萃分析的结果
High Blood Press Cardiovasc Prev. 2020 Apr;27(2):157-164. doi: 10.1007/s40292-020-00370-5. Epub 2020 Mar 26.
5
[Hypolipidemic and antihypertensive therapy in diabetic patients in the Czech Republic: notes on the VZP (General Health Insurance Company) Data].[捷克共和国糖尿病患者的降血脂和抗高血压治疗:关于VZP(国家健康保险公司)数据的注释]
Vnitr Lek. 2015 Nov;61(11 Suppl 3):3S30-7.
6
[Early and concurrent therapy of dyslipidemia and hypertension: when to start it and how to maintain patient´s good and long-term adherence?].
Vnitr Lek. 2021 Winter;67(1):37-40.
7
[Generic drugs: brand names and the placebo effect].[通用药物:品牌名称与安慰剂效应]
Gac Sanit. 2013 Sep-Oct;27(5):468-9. doi: 10.1016/j.gaceta.2012.11.013. Epub 2013 Feb 18.
8
[Use of the EvalObs adherence scale in an unselected French population of treated subjects with antihypertensive, hypolipemiants or oral antidiabetics medications: The FLAHS 2017 adherence survey].[在法国未经过筛选的接受抗高血压药、降血脂药或口服抗糖尿病药治疗的人群中使用EvalObs依从性量表:2017年法国健康与卫生状况及生活方式调查(FLAHS)依从性调查]
Ann Cardiol Angeiol (Paris). 2018 Jun;67(3):186-190. doi: 10.1016/j.ancard.2018.05.002. Epub 2018 May 19.
9
Treating dyslipidemia: something more than giving statins.治疗血脂异常:不仅仅是使用他汀类药物。
Clin Investig Arterioscler. 2019 May-Jun;31(3):119-120. doi: 10.1016/j.arteri.2019.03.003. Epub 2019 Apr 20.
10
Drug therapy of diabetic dyslipidemia: do the statins suffice?糖尿病血脂异常的药物治疗:他汀类药物足够吗?
Am J Ther. 2015 Jan-Feb;22(1):87-8. doi: 10.1097/MJT.0b013e318293b0f9.